Latest News - Waters Corporation

Top Corporates Hub

Waters Corporation

WAT | NYSE | United States
738
+256
Rank
$17.05B
Market Cap
$2.95B
Revenue
$0.84B
+$ 0.22B
+35.48%
Earnings
7.6K
-0.3K
-3.8%
Employees
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

08.06.2026 12:00

55th International Symposium on High Performance Liquid Phase Separations and Related Techniques—Waters Corporation (NYSE: WAT) today announced the launch of the BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and C18+ Columns, a first-of-its-kind reversed-phase (RP) column platform designed to tackle a persistent biopharmaceutical challenge: reliably separating structurally and chemically similar impurities in GLP-1 peptides, insulin, and lipid nanoparticles (LNPs) to support the develo

Read More

2 Unpopular Stocks That Should Get More Attention and 1 We Avoid

08.06.2026 09:57

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Read More

June 2026's Top Stocks Estimated Below Intrinsic Value

05.06.2026 11:38

In the last week, the United States market has stayed flat, yet it has experienced a significant 26% increase over the past year with earnings forecasted to grow by 16% annually. In such a robust environment, identifying stocks that are estimated to be below their intrinsic value can offer investors potential opportunities for growth and value appreciation.

Read More

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

01.06.2026 12:00

74th ASMS Conference on Mass Spectrometry and Allied Topics—Waters Corporation (NYSE: WAT) today introduced the Waters Xevo™ MRT P10 Mass Spectrometer, a high-resolution Quadrupole Time-of-Flight (QToF) System for high-throughput multiomics, bioanalysis, and biopharmaceutical laboratories. The Xevo MRT P10 MS delivers up to 20x higher MS/MS sensitivity compared to its predecessor, along with industry-leading speed and expanded acquisition modes to comprehensively support both targeted and untarg

Read More

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

01.06.2026 12:00

74th ASMS Conference on Mass Spectrometry and Allied Topics— Waters Corporation (NYSE: WAT) today announced the launch of the Waters Cyclic IMS P20 Mass Spectrometer, a high-resolution structural and spatial omics platform designed to help scientists see biology more clearly, and act on it faster. Combining multipass Cyclic Ion Mobility Spectrometry with an enhanced suite of fragmentation, probing, and imaging capabilities, this unique and powerful instrument delivers confident insights for the

Read More

Waters Corporation: Performing Better Than Expected

22.05.2026 11:22

Waters Corporation (WAT) remains a 'Hold'—the merger’s long-term value is still uncertain despite initial optimism and strong revenue growth.

Read More

Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock?

18.05.2026 13:40

After the stock’s decline this year, do Wall Street analysts see a recovery in Becton, Dickinson and Company?

Read More

Understanding Waters (WAT) Reliance on International Revenue

14.05.2026 13:15

Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Read More

D. Mass. Patent Litigation Update: March 2026

12.05.2026 02:13

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.In two related opinions, Judge...

Read More

What Makes Waters Corporation (WAT) an Investment Bet?

11.05.2026 13:11

Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here. In Q1 2026, the Artisan Mid Cap Fund reported negative absolute returns but slightly outperformed the Russell Midcap® Growth Index. The market favored lower volatility and income-oriented equities, […]

Read More

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

05.05.2026 10:00

Waters Corporation (NYSE: WAT), today announced its financial results for the first quarter of 2026, marking the first reporting period that includes financial results for the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company, which was acquired by Waters on February 9, 2026.

Read More

Waters Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026

05.05.2026 08:23

Waters Corporation reported earnings results for the first quarter ended April 04, 2026. For the first quarter, the company reported sales was USD 1,267 million. Net loss was USD 72 million.Basic loss...

Read More

Waters raises annual profit forecast as biosciences unit drives growth

05.05.2026 07:17

Lab equipment maker Watersraised its annual profit forecast on Tuesday after beatingquarterly estimates, driven by robust demand for drugdevelopment tools and the strong performance of its...

Read More

Waters: Q1 Earnings Snapshot

05.05.2026 06:09

MILFORD, Mass. — MILFORD, Mass. — Waters Corp. on Tuesday reported a loss of $72 million in its first quarter. On a per-share basis, the Milford, Massachusetts-based company said it had a...

Read More

Waters : First Quarter 2026 Non-GAAP Addendum

05.05.2026 06:08

Waters Corporation and Subsidiaries Reconciliation of GAAP to Adjusted Non-GAAP Revenue by Operating Segment, Product & Service, and Geography Three Months Ended April 4, 2026 and...

Read More

A Look At Waters (WAT) Valuation As Earnings Optimism And Positive Earnings ESP Build

03.05.2026 09:11

Recent attention on Waters (WAT) centers on its history of earnings surprises and a positive Earnings ESP, with investors watching the May 5, 2026 report as expectations build around upcoming results. See our latest analysis for Waters. Despite optimism around earnings, Waters' recent share price performance has been weak, with a 90 day share price return of a 19.03% decline and a 1 year total shareholder return of a 12.36% decline, suggesting momentum has been fading even as valuation...

Read More

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

28.04.2026 14:00

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

20.04.2026 16:16

MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the...

Read More

EY on the current state of the medtech industry

20.04.2026 15:18

OEMs continue to prioritise high-growth segments of the medtech industry such as pulsed-field ablation (PFA), while conflict in the Middle East is impacting IPO activity.

Read More

9 S&P 500 Stocks Get Green Light To Post Insane Growth This Year

20.04.2026 11:36

Now that fears about the supply of oil are easing, S&P 500 investors are thinking about growth again. And some companies can deliver.

Read More